Nucliq Biologics
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$760,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nucliq Biologics operates in Healthcare & Life Sciences and is based in St. John's, Newfoundland and Labrador. Its latest recorded funding round was a Grant round in January 2024.
Nucliq Biologics is a biotechnology company that develops microbiome-based personalized therapeutics, diagnostics, and at-home testing kits using microbiome science and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucliq Biologics Comparables
Compare Nucliq Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jona | 82% | |
| Biohm Technologies | 81% | |
| Tiny Health | 80% |
For institutional investors. Book with your work email.
Nucliq Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 | ||||
| Grant | Jan 17, 2024 | ||||
| Grant | Jun 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nucliq Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of Newfoundland and Labrador | Grant |
| Memorial Centre for Entrepreneurship | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Atlantic Canada Opportunities Agency | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 29% of headcount.
- Jul 5, 2025
Monthly visitors increased 67% MoM.
For institutional investors. Book with your work email.
Nucliq Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nucliq Biologics's valuation, stock price, and market status.
Is Nucliq Biologics a public or private company?
Nucliq Biologics is a private company.
What is the current stock price of Nucliq Biologics?
Nucliq Biologics is a private company, so its shares have no public market price. Caplight tracks Nucliq Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nucliq Biologics worth (valuation)?
Valuation information for Nucliq Biologics is not publicly available.
Can I buy Nucliq Biologics stock?
Nucliq Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nucliq Biologics's last funding round?
Nucliq Biologics's most recent funding round was Seed on April 24, 2025.
Who are the main investors in Nucliq Biologics?
Key investors in Nucliq Biologics include Government of Newfoundland and Labrador, Memorial Centre for Entrepreneurship, National Research Council Canada Industrial Research Assistance Program, Atlantic Canada Opportunities Agency.
Will Nucliq Biologics IPO soon?
No public IPO plans have been announced for Nucliq Biologics.
How can I track Nucliq Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Nucliq Biologics's shares on secondary markets.